As of 2025-09-18, the Relative Valuation of Arcutis Biotherapeutics Inc (ARQT) is (19.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.14 USD, the upside of Arcutis Biotherapeutics Inc based on Relative Valuation is -212.9%.
The range of the Relative Valuation is (18.43) - (18.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 23.7x | 23.0x |
| Forward P/E multiples | 23.7x - 29.8x | 26.8x |
| Fair Price | (18.43) - (18.43) | (19.35) |
| Upside | -207.6% - -207.6% | -212.9% |
| Date | P/E |
| 2025-09-17 | -22.04 |
| 2025-09-16 | -21.82 |
| 2025-09-15 | -21.77 |
| 2025-09-12 | -22.23 |
| 2025-09-11 | -22.74 |
| 2025-09-10 | -22.59 |
| 2025-09-09 | -23.05 |
| 2025-09-08 | -22.28 |
| 2025-09-05 | -22.05 |
| 2025-09-04 | -20.84 |
| 2025-09-03 | -20.49 |
| 2025-09-02 | -19.70 |
| 2025-08-29 | -19.95 |
| 2025-08-28 | -19.91 |
| 2025-08-27 | -20.12 |
| 2025-08-26 | -20.35 |
| 2025-08-25 | -20.17 |
| 2025-08-22 | -20.55 |
| 2025-08-21 | -20.30 |
| 2025-08-20 | -20.30 |
| 2025-08-19 | -20.27 |
| 2025-08-18 | -21.52 |
| 2025-08-15 | -21.71 |
| 2025-08-14 | -20.54 |
| 2025-08-13 | -20.09 |
| 2025-08-12 | -18.95 |
| 2025-08-11 | -18.24 |
| 2025-08-08 | -18.99 |
| 2025-08-07 | -18.15 |
| 2025-08-06 | -19.75 |
| 2025-08-05 | -19.70 |
| 2025-08-04 | -18.67 |
| 2025-08-01 | -18.37 |
| 2025-07-31 | -18.74 |
| 2025-07-30 | -18.74 |
| 2025-07-29 | -19.27 |
| 2025-07-28 | -19.23 |
| 2025-07-25 | -19.10 |
| 2025-07-24 | -19.31 |
| 2025-07-23 | -19.17 |
| 2025-07-22 | -18.71 |
| 2025-07-21 | -18.44 |
| 2025-07-18 | -18.86 |
| 2025-07-17 | -19.90 |
| 2025-07-16 | -19.84 |
| 2025-07-15 | -19.80 |
| 2025-07-14 | -20.44 |
| 2025-07-11 | -19.30 |
| 2025-07-10 | -19.63 |
| 2025-07-09 | -18.28 |